The US Food and Drug Administration has granted approval to the first non-opioid treatment option for the management of withdrawal symptoms in adults who abruptly discontinue opioids.
The US Food and Drug Administration has expanded the indication of an approved MS drug, making it the first drug approved for use in some pediatric patients with relapsing multiple sclerosis.
The US Food and Drug Administration has expanded the indication of an approved MS drug, making it the first drug approved for use in some pediatric patients with relapsing multiple sclerosis.
The US Food and Drug Administration has expanded the indication of an approved MS drug, making it the first drug approved for use in some pediatric patients with relapsing multiple sclerosis.
The US Food and Drug Administration has approved a supplemental new drug application for the use of a previously approved drug for the treatment of hyperkalemia which may allow for more flexibility and ease...
The US Food and Drug Administration has approved a supplemental new drug application for the use of a previously approved drug for the treatment of hyperkalemia which may allow for more flexibility and ease...
The US Food and Drug Administration has approved a supplemental new drug application for the use of a previously approved drug for the treatment of hyperkalemia which may allow for more flexibility and ease...
